MBX Biosciences, Inc. - Common Stock (MBX)

78 filings reported holding MBX - MBX Biosciences, Inc. - Common Stock as of Q4 2024.
MBX Biosciences, Inc. - Common Stock (MBX) has 63 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 32.9M shares of 44.7M outstanding shares and own 73.76% of the company stock.
Largest 10 shareholders include Frazier Life Sciences Management, L.P. (5.99M shares), ORBIMED ADVISORS LLC (3.81M shares), NEA Management Company, LLC (3.61M shares), Deep Track Capital, LP (3.02M shares), WELLINGTON MANAGEMENT GROUP LLP (2.91M shares), NVP Associates, LLC (2.14M shares), Driehaus Capital Management LLC (1.58M shares), RA CAPITAL MANAGEMENT, L.P. (1.51M shares), EcoR1 Capital, LLC (1.26M shares), and PRICE T ROWE ASSOCIATES INC /MD/ (1.16M shares).
This table shows the top 63 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.